ロード中...
Mesenchymal stromal cell therapy in COPD: from bench to bedside
COPD is the most frequent chronic respiratory disease and a leading cause of morbidity and mortality. The major risk factor for COPD development is cigarette smoke, and the most efficient treatment for COPD is smoking cessation. However, even after smoking cessation, inflammation, apoptosis, and oxi...
保存先:
| 出版年: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5652911/ https://ncbi.nlm.nih.gov/pubmed/29081655 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S146671 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|